HIV-1 Drug Resistance and Third-Line Therapy Outcomes in Patients Failing Second-Line Therapy in Zimbabwe

Chimbetete, Cleophas; Katzenstein, David; Shamu, Tinei; Spoerri, Adrian; Estill, Janne Anton Markus; Egger, Matthias; Keiser, Olivia

doi:10.1093/ofid/ofy005

Scientific article

English

HIV-1 Drug Resistance and Third-Line Therapy Outcomes in Patients Failing Second-Line Therapy in Zimbabwe

ContributorsChimbetete, Cleophas; Katzenstein, David; Shamu, Tinei; Spoerri, Adrian; Estill, Janne Anton Markus; Egger, Matthias; Keiser, Olivia

Published inOpen Forum Infectious Diseases, vol. 5, no. 2

Publication date2018

Abstract

Objectives. To analyze the patterns and risk factors of HIV drug resistance mutations among patients failing second-line treatment and to describe early treatment responses to recommended third-line antiretroviral therapy (ART) in a national referral HIV clinic in Zimbabwe.

Keywords

HIV-1 drug resistance
Second-line therapy
Third-line ART outcomes
Zimbabwe

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de santé et médecine communautaires / Institut de santé globale

Research groups

Maladies infectieuses et modèles mathématiques (988)

Citation (ISO format)

CHIMBETETE, Cleophas et al. HIV-1 Drug Resistance and Third-Line Therapy Outcomes in Patients Failing Second-Line Therapy in Zimbabwe. In: Open Forum Infectious Diseases, 2018, vol. 5, n° 2. doi: 10.1093/ofid/ofy005

Article (Published version)

CC BY-NC-ND

Identifiers

PID : unige:102017
DOI : 10.1093/ofid/ofy005

Journal ISSN2328-8957

697views

294downloads

Creation06/02/2018 16:59:00

First validation06/02/2018 16:59:00

Update15/03/2023 07:50:50

Status update15/03/2023 07:50:50

Last indexation31/10/2024 09:33:42

Archive ouverte UNIGE

HIV-1 Drug Resistance and Third-Line Therapy Outcomes in Patients Failing Second-Line Therapy in Zimbabwe

Objectives. To analyze the patterns and risk factors of HIV drug resistance mutations among patients failing second-line treatment and to describe early treatment responses to recommended third-line antiretroviral therapy (ART) in a national referral HIV clinic in Zimbabwe.

Technical informations